Bloomberg News

Servier Drug Risk Trial Suspended After Challenge, France 3 Says

May 21, 2012

Les Laboratoires Servier and its founder won their bid to suspend a trial over claims they hid the risks of a diabetes drug, when a judge ruled their constitutional challenge to the process was serious enough to merit a higher court’s review, France 3 reported today, citing the judge.

A procedural hearing is planned for Dec. 14 to reschedule the trial, pending the outcome of the constitutional review, France 3 said on its website.

To contact the reporter on this story: Heather Smith in Paris at hsmith26@bloomberg.net

To contact the editor responsible for this story: Anthony Aarons at aaarons@bloomberg.net


Toyota's Hydrogen Man
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus